Earticle

초록

영어

Objectives: Using data on 86 Korean pharmaceutical firms over a 5-year period from 2013 to 2017, this study empirically analyzes the relationship between research and development (R&D) investment and firm-specific factors. Methods: Investment variables are R&D expenditure and intensity. Variables for firm-specific factors include firm size, firm age, firm location, technological innovation, and export orientation. Nonparametric statistical methods are used to test the difference in R&D investment and groups are then classified according to the level of firm-specific factors for inter- or between-group comparison. Results: First, R&D intensity was related to firm size, firm age, and technological innovation. Second, R&D expenditure was related to firm size and technological innovation and this relationship was statistically significant. Conclusions: The results are expected to provide policy implications for R&D investment decisions and strategic choices made by managers as well as policy makers.

목차

Ⅰ. 서론
Ⅱ. 연구방법
1. 연구대상 및 자료수집
2. 변수의 선정 및 분석 기준
3. 자료 분석방법
Ⅲ. 연구결과
1. 표본기업의 특성
2. R&D집약도 차이 검정 결과
3. R&D투자액 차이 검정 결과
Ⅳ. 고찰
Ⅴ. 결론
REFERENCES

키워드

저자

• 이철행 [ Cheol-Haeng Lee | 한국보건산업진흥원 ]
• 이상원 [ Sang-Won Lee | 성균관대학교 약학대학 ] Corresponding Author

참고문헌

발행기관

간행물

표지보기 관심저널 등록

• 간행물명

  보건의료산업학회지 [The Korean Journal of Health Service Management]

• 간기

  계간

• pISSN

  2093-5986

• 수록기간

  2007~2026

• 등재여부

  KCI 등재

• 십진분류

  KDC 517 DDC 613